• Inicio
  • Formações
  • Formação à Medida
  • News & Trends
  • Sobre nós
  • Contacto

Updated: ICH Q12: A Framework for Managing Post-Approval CMC Changes

The US Food and Drug Administration (FDA) made available an International Council for Harmonisation (ICH) draft guidance on technical and regulatory considerations for pharmaceutical lifecycle management.

Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management

Q12 Annex

News & Trends

Procurar

Recentes

  • HTA Regulation – Commission selects first medical devices for joint clinical assessment
  • PHARMACOVIGILANCE UPDATE | FDA E2B(R3) IMPLEMENTATION GUIDE — OCTOBER 2026
  • updated PIC/S PI 006-4 guideline RECOMMENDATIONS ON QUALIFICATION AND VALIDATION
  • Annual report of the Pharmacovigilance Inspectors Working Group for 2025
  • European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
  • ACT EU workplan 2026 – 2027
  • Advice on ‘end-of-year’ submission dates for type I variations in 2026
  • EMA UPDATE : COMPLIANCE with EU GMP Annex 22 and Artificial Intelligence Standards

91 257 00 03 (Chamada para a rede móvel nacional)
info@formiventos.com

  • Follow
  • CLIENTES & TESTIMONIALS
  • ASSOCIAÇÕES OFICIAIS
  • CERTIFICAÇÕES E CREDITAÇÕES
  • ADVISORY BOARD
  • Política de Privacidade
  • Contacto